PDT Partners, LLC - Q2 2016 holdings

$1.26 Billion is the total value of PDT Partners, LLC's 441 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 0.0% .

 Value Shares↓ Weighting
CHRW  C H ROBINSON WORLDWIDE INC$6,749,000
+0.0%
90,9000.0%0.54%
+26.5%
WOOF  VCA INC$6,294,000
+17.2%
93,1000.0%0.50%
+48.5%
CRL  CHARLES RIV LABS INTL INC$6,183,000
+8.5%
75,0000.0%0.49%
+37.3%
CME  CME GROUP INC$5,844,000
+1.4%
60,0000.0%0.46%
+28.3%
Q  QUINTILES TRANSNATIO HLDGS I$5,467,000
+0.3%
83,7000.0%0.43%
+27.0%
VRTX  VERTEX PHARMACEUTICALS INC$5,154,000
+8.2%
59,9200.0%0.41%
+36.9%
ARIA  ARIAD PHARMACEUTICALS INC$4,568,000
+15.6%
618,1870.0%0.36%
+46.6%
LDOS  LEIDOS HLDGS INC$4,280,000
-4.9%
89,4000.0%0.34%
+20.2%
MYGN  MYRIAD GENETICS INC$4,269,000
-18.2%
139,5000.0%0.34%
+3.4%
JNS  JANUS CAP GROUP INC$4,186,000
-4.8%
300,7000.0%0.33%
+20.7%
NXST  NEXSTAR BROADCASTING GROUP Icl a$3,239,000
+7.5%
68,0790.0%0.26%
+36.0%
TECH  BIO TECHNE CORP$3,236,000
+19.3%
28,7000.0%0.26%
+50.6%
FET  FORUM ENERGY TECHNOLOGIES IN$3,047,000
+31.2%
176,0000.0%0.24%
+66.2%
AXL  AMERICAN AXLE & MFG HLDGS IN$2,948,000
-5.9%
203,6000.0%0.23%
+19.4%
NKTR  NEKTAR THERAPEUTICS$2,890,000
+3.5%
203,1000.0%0.23%
+30.9%
INT  WORLD FUEL SVCS CORP$2,850,000
-2.2%
60,0080.0%0.23%
+23.5%
EXAS  EXACT SCIENCES CORP$2,813,000
+81.7%
229,6000.0%0.22%
+129.9%
POL  POLYONE CORP$2,795,000
+16.5%
79,3010.0%0.22%
+47.3%
OTEX  OPEN TEXT CORP$2,285,000
+14.2%
38,6290.0%0.18%
+44.8%
GRPN  GROUPON INC$2,204,000
-18.5%
678,0000.0%0.18%
+3.6%
MDR  MCDERMOTT INTL INC$2,074,000
+20.8%
419,9000.0%0.16%
+51.9%
TLN  TALEN ENERGY CORP$2,028,000
+50.6%
149,7000.0%0.16%
+91.7%
SUPN  SUPERNUS PHARMACEUTICALS INC$1,988,000
+33.6%
97,6000.0%0.16%
+68.8%
EBIX  EBIX INC$1,930,000
+17.4%
40,3000.0%0.15%
+48.5%
CHE  CHEMED CORP NEW$1,786,000
+0.7%
13,1000.0%0.14%
+27.0%
USNA  USANA HEALTH SCIENCES INC$1,683,000
-8.2%
15,1000.0%0.13%
+15.7%
IRBT  IROBOT CORP$1,600,000
-0.6%
45,6000.0%0.13%
+25.7%
SLAB  SILICON LABORATORIES INC$1,311,000
+8.4%
26,9000.0%0.10%
+36.8%
NEOG  NEOGEN CORP$1,108,000
+11.7%
19,7000.0%0.09%
+41.9%
MLI  MUELLER INDS INC$796,000
+8.3%
24,9760.0%0.06%
+37.0%
GHDX  GENOMIC HEALTH INC$776,000
+4.6%
29,9630.0%0.06%
+32.6%
KWR  QUAKER CHEM CORP$633,000
+5.1%
7,0990.0%0.05%
+31.6%
SCLN  SCICLONE PHARMACEUTICALS INC$617,000
+18.7%
47,2290.0%0.05%
+48.5%
UTEK  ULTRATECH INC$606,000
+5.0%
26,4000.0%0.05%
+33.3%
TUESQ  TUESDAY MORNING CORP$502,000
-14.2%
71,5000.0%0.04%
+8.1%
AMRI  ALBANY MOLECULAR RESH INC$476,000
-12.0%
35,4000.0%0.04%
+11.8%
NPK  NATIONAL PRESTO INDS INC$462,000
+12.7%
4,9000.0%0.04%
+42.3%
MED  MEDIFAST INC$453,000
+10.2%
13,6100.0%0.04%
+38.5%
WSFS  WSFS FINL CORP$437,000
-0.9%
13,5740.0%0.04%
+25.0%
MG  MISTRAS GROUP INC$387,000
-3.5%
16,2000.0%0.03%
+24.0%
GLBL  TERRAFORM GLOBAL INCcl a$341,000
+36.9%
104,6000.0%0.03%
+68.8%
ATRI  ATRION CORP$300,000
+8.3%
7000.0%0.02%
+41.2%
ARCO  ARCOS DORADOS HOLDINGS INC$284,000
+27.4%
59,5000.0%0.02%
+57.1%
PRMW  PRIMO WTR CORP$191,000
+17.2%
16,2000.0%0.02%
+50.0%
MYE  MYERS INDS INC$150,000
+11.9%
10,4000.0%0.01%
+50.0%
ACRX  ACELRX PHARMACEUTICALS INC$149,000
-12.9%
55,3990.0%0.01%
+9.1%
ONE  HIGHER ONE HLDGS INC$118,000
+31.1%
23,0000.0%0.01%
+50.0%
ANGI  ANGIES LIST INC$118,000
-19.2%
18,1500.0%0.01%0.0%
CNTY  CENTURY CASINOS INC$78,000
+1.3%
12,4460.0%0.01%
+20.0%
HNRG  HALLADOR ENERGY COMPANY$62,000
+1.6%
13,4000.0%0.01%
+25.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CME GROUP INC45Q2 20241.7%
ZOETIS INC41Q2 20241.4%
IMAX CORP39Q2 20240.3%
TREX CO INC38Q3 20230.6%
ARCOS DORADOS HOLDINGS INC38Q2 20240.2%
MASTERCARD INCORPORATED36Q2 20231.8%
SILICON LABORATORIES INC36Q2 20240.6%
EOG RES INC35Q2 20221.7%
LOGITECH INTL S A35Q2 20240.7%
CHARLES RIV LABS INTLINC34Q2 20241.0%

View PDT Partners, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-08-15
N-PX2024-08-07
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
40-6B/A2023-09-29
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14

View PDT Partners, LLC's complete filings history.

Compare quarters

Export PDT Partners, LLC's holdings